Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice

N Hattan, H Kawaguchi, K Ando… - Cardiovascular …, 2005 - academic.oup.com
Objective: We have previously isolated cardiomyogenic cells from murine bone marrow (CMG
cells). Regenerated cardiomyocytes are important candidates for cell transplantation, but …

Angiostatin and matrix metalloprotease expression following ischemic acute renal failure

…, K Fredrich, D Weihrauch, N Hattan… - American Journal …, 2004 - journals.physiology.org
Ischemic injury to the kidney results in blood vessel loss and predisposition to chronic renal
disease. Angiostatin is a proteolytic cleavage product of plasminogen that inhibits …

Application of mesenchymal stem cell-derived cardiomyocytes as bio-pacemakers: current status and problems to be solved

Y Tomita, S Makino, D Hakuno, N Hattan… - Medical & biological …, 2007 - Springer
Bone marrow mesenchymal stem cells (CMG cells) are multipotent and can be induced by 5-azacytidine
to differentiate into cardiomyocytes. We characterized the electrophysiological …

Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD

N Hattan, WM Chilian, F Park, P Rocic - Basic research in cardiology, 2007 - Springer
The metabolic syndrome (MS), a condition characterized by several risk factors for coronary
artery disease, including obesity, is associated with endothelial dysfunction and oxidative …

Autologous vascular smooth muscle cell-based myocardial gene therapy to induce coronary collateral growth

N Hattan, D Warltier, W Gu, C Kolz… - American Journal …, 2004 - journals.physiology.org
For therapeutic angiogenesis to achieve clinical relevance, it must be effective, with minimal
side effects to other end organ systems. We developed a cardiac-specific gene delivery …

[HTML][HTML] Amelioration of microvascular myocardial ischemia by gene transfer of vascular endothelial growth factor in rabbits

E Tanaka, N Hattan, K Ando, H Ueno, Y Sugio… - The Journal of Thoracic …, 2000 - Elsevier
Objectives: Restoration of coronary blood flow by angiogenesis may offer a new approach
to intractable ischemic heart disease. In the present study, we investigated the angiogenic …

Regulation of the coronary vasomotor tone: what we know and where we need to go

E Toyota, R Koshida, N Hattan, WM Chilian - Journal of Nuclear …, 2001 - Springer
The control of coronary blood flow has been studied for decades, but despite our extensive
efforts, the critical regulators of flow are largely unknown. One purpose of this review is to …

Increased plasma tetrahydrobiopterin in septic shock is a possible therapeutic target

K Hoshiai, N Hattan, N Fukuyama, F Tadaki, M Hida… - Pathophysiology, 2001 - Elsevier
Hemoperfusion with a column of polymyxin B immobilized on fibers (PMX) has been used to
adsorb endotoxin in-patients with septic shock. PMX hemoperfusion (PMX-H) increases …

Transmyocardial revascularization aggravates myocardial ischemia around the channels in the immediate phase

N Hattan, K Ban, E Tanaka, S Abe… - American Journal …, 2000 - journals.physiology.org
We examined whether transmyocardial revascularization (TMR) relieves myocardial ischemia
by increasing regional perfusion via the transmural channels in acute canine experiments. …

Impaired sarcoplasmic reticulum function in lipopolysaccharide-induced myocardial dysfunction demonstrated in whole heart

M Hoshiai, N Hattan, Y Hirota, K Hoshiai, H Ishida… - Shock, 1999 - journals.lww.com
To clarify the pathophysiological cascade leading to lipopolysaccharide-(LPS) induced
myocardial dysfunction, we measured sarcoplasmic reticulum (SR) function, expression of …